Page last updated: 2024-10-16

gamma-aminobutyric acid and Arteriosclerosis, Coronary

gamma-aminobutyric acid has been researched along with Arteriosclerosis, Coronary in 2 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, CH1
Yu, SM1
Lau, SC1
Chen, YL1
Pei, D1
Liu, IC1
Gargiulo, R1
Suhail, F1
Lerma, EV1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Identifying a Cardiorenal Protective Diet in a Lower-income African American Population With Chronic Kidney Disease at Risk for Cardiovascular Disease.[NCT04117204]101 participants (Actual)Interventional2019-06-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for gamma-aminobutyric acid and Arteriosclerosis, Coronary

ArticleYear
Cardiovascular disease and chronic kidney disease.
    Disease-a-month : DM, 2015, Volume: 61, Issue:9

    Topics: Cardiovascular Diseases; Coronary Artery Disease; gamma-Aminobutyric Acid; Heart Diseases; Humans; P

2015

Other Studies

1 other study available for gamma-aminobutyric acid and Arteriosclerosis, Coronary

ArticleYear
Restless legs syndrome/Willis-Ekbom disease in type 2 diabetes as the initial manifestation of Parkinson's disease and major cardiovascular disease.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2017, Volume: 17, Issue:6

    Topics: Aged; Amines; Analgesics; Anticonvulsants; Antihypertensive Agents; Antiparkinson Agents; Aspirin; B

2017